From: A categorical network approach for discovering differentially expressed regulations in cancer
Pathway | BNKL | SVM | LAS | PC |
---|---|---|---|---|
Axon guidance | 0.87 | 0.93 | 0.83 | 0.70 |
Melanogenesis | 0.92 | 0.83 | 0.66 | 0.72 |
Tight junction | 0.92 | 0.88 | 0.89 | 0.73 |
p53 signaling pathway | 0.92 | 0.91 | 0.76 | 0.72 |
Pathways in cancer | 0.89 | 0.86 | 0.91 | 0.74 |
Complement and coagulation cascades | 0.75 | 0.91 | 0.74 | 0.52 |
Fructose and mannose metabolism | 0.82 | 0.91 | 0.82 | 0.60 |
Chronic myeloid leukemia | 0.86 | 0.91 | 0.74 | 0.72 |
Bile secretion | 0.90 | 0.87 | 0.72 | 0.67 |
Small cell lung cancer | 0.87 | 0.90 | 0.71 | 0.69 |
Wnt signaling pathway | 0.90 | 0.84 | 0.69 | 0.64 |
Cell adhesion molecules (CAMs) | 0.88 | 0.90 | 0.67 | 0.53 |
Leukocyte transendothelial migration | 0.90 | 0.89 | 0.81 | 0.54 |
Endocytosis | 0.90 | 0.88 | 0.86 | 0.67 |
Non-small cell lung cancer | 0.90 | 0.89 | 0.74 | 0.77 |
T cell receptor signaling pathway | 0.88 | 0.88 | 0.76 | 0.74 |